- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 2 x XZ4: methyl 2-[[3-[[2,4-bis(fluoranyl)phenyl]methylcarbamoyl]-7-methoxy-1-oxidanyl-2-oxidanylidene-1,8-naphthyridin-4-yl]amino]ethanoate(Non-covalent)
XZ4.3: 15 residues within 4Å:- Chain A: D.131, Y.132, D.188, G.190, Y.215, P.217, Q.218, E.224
- Chain C: G.4
- Chain D: C.16, A.17
- Ligands: MG.1, MG.2, SO4.8, MES.15
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:P.217, A:E.224
- Water bridges: A:Y.132, A:Y.132, A:N.227
XZ4.24: 15 residues within 4Å:- Chain E: D.131, Y.132, D.188, G.190, Y.215, P.217, Q.218, E.224
- Chain G: G.4
- Chain H: C.16, A.17
- Ligands: MG.22, MG.23, SO4.29, MES.36
7 PLIP interactions:7 interactions with chain E- Hydrophobic interactions: E:P.217, E:E.224
- Hydrogen bonds: E:E.224
- Water bridges: E:Y.132, E:Y.132, E:D.188, E:N.227
- 2 x ZN: ZINC ION(Non-covalent)
ZN.4: 4 residues within 4Å:- Chain A: H.65, H.69, C.99, C.102
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:H.65, A:H.69, A:C.99, A:C.102
ZN.25: 4 residues within 4Å:- Chain E: H.65, H.69, C.99, C.102
4 PLIP interactions:4 interactions with chain E- Metal complexes: E:H.65, E:H.69, E:C.99, E:C.102
- 16 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 5 residues within 4Å:- Chain A: R.117, Y.306, P.308
- Chain C: C.6
- Ligands: GOL.20
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: P.118, D.119
- Chain C: T.3
Ligand excluded by PLIPSO4.7: 3 residues within 4Å:- Chain A: S.139, Q.140, K.244
Ligand excluded by PLIPSO4.8: 7 residues within 4Å:- Chain A: D.188, Q.189, G.190, P.214, Y.215
- Ligands: XZ4.3, MES.15
Ligand excluded by PLIPSO4.9: 4 residues within 4Å:- Chain A: K.231
- Chain E: S.335, L.336, R.339
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain A: H.341, K.342, H.360
Ligand excluded by PLIPSO4.18: 5 residues within 4Å:- Chain B: K.222, R.225, S.261, P.262, V.263
Ligand excluded by PLIPSO4.21: 6 residues within 4Å:- Chain A: K.231, R.232, T.235
- Chain D: A.15, C.16
- Chain E: R.339
Ligand excluded by PLIPSO4.26: 5 residues within 4Å:- Chain E: R.117, Y.306, P.308
- Chain G: C.6
- Ligands: GOL.41
Ligand excluded by PLIPSO4.27: 3 residues within 4Å:- Chain E: P.118, D.119
- Chain G: T.3
Ligand excluded by PLIPSO4.28: 3 residues within 4Å:- Chain E: S.139, Q.140, K.244
Ligand excluded by PLIPSO4.29: 7 residues within 4Å:- Chain E: D.188, Q.189, G.190, P.214, Y.215
- Ligands: XZ4.24, MES.36
Ligand excluded by PLIPSO4.30: 4 residues within 4Å:- Chain A: S.335, L.336, R.339
- Chain E: K.231
Ligand excluded by PLIPSO4.31: 3 residues within 4Å:- Chain E: H.341, K.342, H.360
Ligand excluded by PLIPSO4.39: 5 residues within 4Å:- Chain F: K.222, R.225, S.261, P.262, V.263
Ligand excluded by PLIPSO4.42: 6 residues within 4Å:- Chain A: R.339
- Chain E: K.231, R.232, T.235
- Chain H: A.15, C.16
Ligand excluded by PLIP- 12 x GOL: GLYCEROL(Non-functional Binders)
GOL.11: 5 residues within 4Å:- Chain A: Q.63, L.82, Y.83
- Chain E: P.280, F.281
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain A- Hydrogen bonds: E:F.281, A:Q.63, A:Y.83
GOL.12: 3 residues within 4Å:- Chain A: S.165, T.166, S.167
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.166, A:T.166, A:S.167, A:S.167
GOL.13: 7 residues within 4Å:- Chain A: L.295, Q.299
- Chain B: Y.266, Q.270, G.274, I.275, D.276
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:Y.266, B:G.274, B:D.276, B:D.276
GOL.14: 4 residues within 4Å:- Chain A: G.21, H.22, Y.23, K.29
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.29, A:K.29
GOL.19: 3 residues within 4Å:- Chain B: S.220, G.221, R.225
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:G.221, B:R.225
GOL.20: 7 residues within 4Å:- Chain A: V.263
- Chain C: C.6, A.7, T.8
- Chain D: C.11, A.12
- Ligands: SO4.5
1 PLIP interactions:1 interactions with chain A- Water bridges: A:V.263
GOL.32: 5 residues within 4Å:- Chain A: P.280, F.281
- Chain E: Q.63, L.82, Y.83
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain E- Hydrogen bonds: A:F.281, E:Q.63, E:Y.83, E:Y.83
GOL.33: 3 residues within 4Å:- Chain E: S.165, T.166, S.167
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:T.166, E:S.167, E:S.167
GOL.34: 7 residues within 4Å:- Chain E: L.295, Q.299
- Chain F: Y.266, Q.270, G.274, I.275, D.276
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:Y.266, F:G.274, F:D.276
GOL.35: 4 residues within 4Å:- Chain E: G.21, H.22, Y.23, K.29
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:K.29, E:K.29
GOL.40: 3 residues within 4Å:- Chain F: S.220, G.221, R.225
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:G.221, F:R.225
GOL.41: 7 residues within 4Å:- Chain E: V.263
- Chain G: C.6, A.7, T.8
- Chain H: C.11, A.12
- Ligands: SO4.26
1 PLIP interactions:1 interactions with chain E- Water bridges: E:V.263
- 2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
MES.15: 7 residues within 4Å:- Chain A: Q.189, Y.215, R.332
- Chain D: A.17
- Ligands: XZ4.3, SO4.8, HEZ.16
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.332
MES.36: 7 residues within 4Å:- Chain E: Q.189, Y.215, R.332
- Chain H: A.17
- Ligands: XZ4.24, SO4.29, HEZ.37
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:Y.215
- Salt bridges: E:R.332
- 2 x HEZ: HEXANE-1,6-DIOL(Non-covalent)
HEZ.16: 6 residues within 4Å:- Chain A: Y.215, V.330, A.331, H.341, R.365
- Ligands: MES.15
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:Y.215, A:A.331
- Hydrogen bonds: A:A.331, A:H.341, A:R.365, A:R.365
HEZ.37: 6 residues within 4Å:- Chain E: Y.215, V.330, A.331, H.341, R.365
- Ligands: MES.36
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:Y.215, E:A.331
- Hydrogen bonds: E:A.331, E:H.341, E:R.365, E:R.365
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, X.Z. et al., Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors. J. Med. Chem. (2017)
- Release Date
- 2017-08-02
- Peptides
- Integrase: ABEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 2 x XZ4: methyl 2-[[3-[[2,4-bis(fluoranyl)phenyl]methylcarbamoyl]-7-methoxy-1-oxidanyl-2-oxidanylidene-1,8-naphthyridin-4-yl]amino]ethanoate(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- 16 x SO4: SULFATE ION(Non-functional Binders)
- 12 x GOL: GLYCEROL(Non-functional Binders)
- 2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 2 x HEZ: HEXANE-1,6-DIOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, X.Z. et al., Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors. J. Med. Chem. (2017)
- Release Date
- 2017-08-02
- Peptides
- Integrase: ABEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BE
AF
B